DrugPatentWatch Database Preview
Profile for Canada Patent: 2432000
US Patent Family Members and Approved Drugs for Canada Patent: 2432000
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 19, 2023 | Novartis | VOTRIENT | pazopanib hydrochloride |
Start Trial | Dec 19, 2021 | Novartis | VOTRIENT | pazopanib hydrochloride |
Start Trial | Dec 19, 2021 | Novartis | VOTRIENT | pazopanib hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |